{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T21:12:47Z","timestamp":1723324367700},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,6]],"date-time":"2012-11-06T00:00:00Z","timestamp":1352160000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00467-012-2332-4","type":"journal-article","created":{"date-parts":[[2012,11,5]],"date-time":"2012-11-05T01:44:56Z","timestamp":1352079896000},"page":"511-514","source":"Crossref","is-referenced-by-count":3,"title":["Late recovery of renal function by rituximab in a patient with Wegener\u2019s granulomatosis"],"prefix":"10.1007","volume":"28","author":[{"given":"Michal","family":"Malina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Betti","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00fcdiger","family":"Waldherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"W\u00fchl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus Peter","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,6]]},"reference":[{"key":"2332_CR1","doi-asserted-by":"crossref","first-page":"440","DOI":"10.3899\/jrheum.090688","volume":"37","author":"S Grisaru","year":"2010","unstructured":"Grisaru S, Yuen GW, Miettunen PM, Hamiwka LA (2010) Incidence of Wegener\u2019s granulomatosis in children. J Rheumatol 37:440\u2013442","journal-title":"J Rheumatol"},{"key":"2332_CR2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/art.22774","volume":"57","author":"JD Akikusa","year":"2007","unstructured":"Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, Silverman ED (2007) Clinical features and outcome of pediatric Wegener\u2019s granulomatosis. Arthritis Rheum 57:837\u2013844","journal-title":"Arthritis Rheum"},{"key":"2332_CR3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s00467-002-0914-2","volume":"17","author":"VM Belostotsky","year":"2002","unstructured":"Belostotsky VM, Shah V, Dillon MJ (2002) Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol 17:754\u2013761","journal-title":"Pediatr Nephrol"},{"key":"2332_CR4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1136\/ard.2009.116657","volume":"69","author":"S Ozen","year":"2010","unstructured":"Ozen S, Pistorio A, Iusan SM, Bakkaloglu A, Herlin T, Brik R, Buoncompagni A, Lazar C, Bilge I, Uziel Y, Rigante D, Cantarini L, Hilario MO, Silva CA, Alegria M, Norambuena X, Belot A, Berkun Y, Estrella AI, Olivieri AN, Alpigiani MG, Rumba I, Sztajnbok F, Tambic-Bukovac L, Breda L, Al-Mayouf S, Mihaylova D, Chasnyk V, Sengler C, Klein-Gitelman M, Djeddi D, Nuno L, Pruunsild C, Brunner J, Kondi A, Pagava K, Pederzoli S, Martini A, Ruperto N (2010) EULAR\/PRINTO\/PRES criteria for Henoch\u2013Sch\u00f6nlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria. Ann Rheum Dis 69:798\u2013806","journal-title":"Ann Rheum Dis"},{"key":"2332_CR5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/rheumatology\/ker150","volume":"51","author":"MJ Guerry","year":"2011","unstructured":"Guerry MJ, Brogan P, Bruce IN, D\u2019Cruz DP, Harper L, Luqmani R, Pusey CD, Salama AD, Scott DG, Savage CO, Watts RA, Jayne DR (2011) Recommendations for the use of rituximab in anti-neutrophil cytoplasm antibody-associated vasculitis. Rheumatology (Oxford) 51:634\u2013643","journal-title":"Rheumatology (Oxford)"},{"key":"2332_CR6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T, Luqmani R, Morgan MD, Peh CA, Savage CO, Segelmark M, Tesar V, van Paassen P, Walsh D, Walsh M, Westman K, Jayne DR (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211\u2013220","journal-title":"N Engl J Med"},{"key":"2332_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"2332_CR8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/BOR.0b013e32834d5730","volume":"24","author":"R Cartin-Ceba","year":"2012","unstructured":"Cartin-Ceba R, Fervenza FC, Specks U (2012) Treatment of antineutrophil cytoplasmic antibody-associated vasculitis with rituximab. Curr Opin Rheumatol 24:15\u201323","journal-title":"Curr Opin Rheumatol"},{"key":"2332_CR9","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/ndt\/gfr507","volume":"26","author":"JW Cohen Tervaert","year":"2011","unstructured":"Cohen Tervaert JW (2011) Rituximab in ANCA-associated vasculitis: a revolution? Nephrol Dial Transplant 26:3077\u20133079","journal-title":"Nephrol Dial Transplant"},{"key":"2332_CR10","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.4076\/1757-1626-2-6609","volume":"2","author":"N Tzaribachev","year":"2009","unstructured":"Tzaribachev N, Koetter I, Kuemmerle-Deschner JB, Schedel J (2009) Rituximab for the treatment of refractory pediatric autoimmune diseases: a case series. Cases J 2:6609","journal-title":"Cases J"},{"key":"2332_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2169\/internalmedicine.46.6156","volume":"46","author":"N Tamura","year":"2007","unstructured":"Tamura N, Matsudaira R, Hirashima M, Ikeda M, Tajima M, Nawata M, Morimoto S, Kaneda K, Kobayashi S, Hashimoto H, Takasaki Y (2007) Two cases of refractory Wegener\u2019s granulomatosis successfully treated with rituximab. Intern Med 46:409\u2013414","journal-title":"Intern Med"},{"key":"2332_CR12","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/rheumatology\/kep148","volume":"48","author":"D Eleftheriou","year":"2009","unstructured":"Eleftheriou D, Melo M, Marks SD, Tullus K, Sills J, Cleary G, Dolezalova P, Ozen S, Pilkington C, Woo P, Klein N, Dillon MJ, Brogan PA (2009) Biologic therapy in primary systemic vasculitis of the young. Rheumatology (Oxford) 48:978\u2013986","journal-title":"Rheumatology (Oxford)"},{"key":"2332_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1681\/ASN.2011040330","volume":"23","author":"AE Berden","year":"2012","unstructured":"Berden AE, Jones RB, Erasmus DD, Walsh M, Noel LH, Ferrario F, Waldherr R, Bruijn JA, Jayne DR, Bajema IM (2012) Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol 23:313\u2013321","journal-title":"J Am Soc Nephrol"},{"key":"2332_CR14","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/art.30314","volume":"63","author":"FL Veerdonk van de","year":"2011","unstructured":"van de Veerdonk FL, Lauwerys B, Marijnissen RJ, Timmermans K, Di Padova F, Koenders MI, Gutierrez-Roelens I, Durez P, Netea MG, van der Meer JW, van den Berg WB, Joosten LA (2011) The anti-CD20 antibody rituximab reduces the Th17 cell response. Arthritis Rheum 63:1507\u20131516","journal-title":"Arthritis Rheum"},{"key":"2332_CR15","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2010.472","volume":"79","author":"B Wilde","year":"2011","unstructured":"Wilde B, van Paassen P, Witzke O, Tervaert JW (2011) New pathophysiological insights and treatment of ANCA-associated vasculitis. Kidney Int 79:599\u2013612","journal-title":"Kidney Int"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2332-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-012-2332-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-012-2332-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:03:54Z","timestamp":1559091834000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-012-2332-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,6]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["2332"],"URL":"https:\/\/doi.org\/10.1007\/s00467-012-2332-4","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,6]]}}}